Eli Lilly (LLY) Other Operating Expenses (2012 - 2019)

Eli Lilly (LLY) has 8 years of Other Operating Expenses data on file, last reported at -$151.7 million in Q4 2019.

• For the quarter ending Q4 2019, Other Operating Expenses rose 21.24% year-over-year to -$151.7 million; the trailing twelve-month figure through Sep 2020 stood at -$151.7 million (up 75.39% YoY), and the FY2019 full-year result was -$9.1 billion, down 10.93% from the prior year.
• Other Operating Expenses for Q4 2019 stood at -$151.7 million, up from -$423.9 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $5.0 billion in Q4 2016 and bottomed at -$423.9 million in Q1 2019.
• The 5-year median for Other Operating Expenses is -$57.4 million (2016), against an average of $220.6 million.
• The widest annual swing landed in 2016, when Other Operating Expenses jumped 3526.71%; it then plunged 793.41% in 2017.
• A 5-year view of Other Operating Expenses shows it stood at -$144.9 million in 2015, then surged by 3526.71% to $5.0 billion in 2016, then sank by 100.89% to -$44.4 million in 2017, then tumbled by 333.78% to -$192.6 million in 2018, then grew by 21.24% to -$151.7 million in 2019.
• The last three Other Operating Expenses figures came in at -$151.7 million (Q4 2019), -$423.9 million (Q1 2019), and -$192.6 million (Q4 2018), per Business Quant data.

Peer Comparison